Intriguingly, unlike the ER+ breast cancer cell lines which have robust Sox2 expression [10], we discovered that TNBC cells showed little to no expression of Sox2, and Sox2 was not a driver of the SRR2 reporter response [9]. Here, ESR1 is linked to breast carcinoma.